.
20 () , - CD3+19- 64,64+2,02% 66,44+1,66% (>0.05), 1,330,04 1,41+0,03 (<0,05).
42,763,64% 57,07+2,19% (<0,01), 3,61 0,53 5,750,63 (<0,01).
() , IgA 1,49+0,08 1,64+0,11 / (<0,05).
, () , .
(). : h 134,2 (11,0 . ( 98,0 (13,7, ., >0,05): S 60326,0 (7821,0 . ( 40275,0 (9340.0 ., (0,05); h 167,8 (12,7 . ( 165,2 (15,3 ., (0,05); S 60142,0 (4217,0 . ( 55374,0 (8769,0 ., (0,05).
(), : h 47,1 % (134,2 (1 1,0) . (71,0 (8,6) ., (0,05); S 48,3 % (60326.0 (7821,0) . (31192,0 (4414,0) ., (0.05); h 32,1 % (167,8 (12,7) . (113,9(1 1,8) ., (0,05). S (60142+4217) . (501375610) ., >0.05.
, .
, -, .
, () . 20 137Cs 57,9% ( 27,0%).
|
|
() 20 , - , - . .
() , - , IgA ; .
() 20 , .
() . , .